£425.00

It has never been this cheap. We have no record of a lower price.

£425 today · cheaper than every other day in the last 3 months

Anti-Migraine Drug Outlook Latin America 2016-2021 Study

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 89 days · 89 data points

Historical
Generating forecast…
£425.00 £403.75 £412.25 £420.75 £429.25 £437.75 £446.25 11 August 2026 02 September 2026 24 September 2026 16 October 2026 07 November 2026
View at Amazon ↗

Price data checked 2 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 89 days • 1 price levels

Days at Price
89 days 0 22 45 67 89 £425 Days at Price

Price Analysis

Most common price: £425 (89 days, 100.0%)

Price range: £425 - £425

Price levels: 1 different prices over 89 days

Description

This econometric study provides a detailed outlook for anti-migraine drugs in the Latin American market from 2016 to 2021. By utilizing econometric models that project fundamental economic dynamics both within and across countries, the report generates latent demand estimates. Readers can access estimates for potential industry earnings (P.I.E.) in millions of U.S. dollars for each reported year. The study includes the percent share each country holds within the region and the global market. These comparative benchmarks allow for a quick assessment of specific countries in relation to others. This professional resource is designed for those analyzing economic trends and market potential in the pharmaceutical sector.

Key Features

Provides econometric models that project fundamental economic dynamics for each country and across the Latin American region.

Includes latent demand estimates expressed as potential industry earnings (P.I.E.) in millions of U.S. dollars.

Offers comparative benchmarks by reporting the percent share each country holds of the region and the globe.

Covers the specific outlook for anti-migraine drugs throughout the 2016-2021 period.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
21 May 2015
Listed Since
01 October 2015

Similar Products You Might Like

Anti-Migraine Drug Outlook in Asia 2016-2021 Study
99% match

Anti-Migraine Drug Outlook in Asia 2016-2021 Study

£425.00 06 Nov 2026
Anti-Migraine Drugs in Europe Outlook 2016-2021 Report
99% match

Anti-Migraine Drugs in Europe Outlook 2016-2021 Report

£425.00 09 Nov 2026
Anti-Migraine Drug Outlook North America & Caribbean Study
99% match

Anti-Migraine Drug Outlook North America & Caribbean Study

£425.00 05 Nov 2026
Anti-Migraine Drug Outlook in Oceana 2016-2021 Study
99% match

Anti-Migraine Drug Outlook in Oceana 2016-2021 Study

£425.00 26 Sep 2026
Anti-Migraine Drug Outlook in Middle East (2011-2016)
99% match

Anti-Migraine Drug Outlook in Middle East (2011-2016)

£325.00 09 Nov 2026
The 2021-2026 World Outlook for Anti-Migraine Drugs
99% match

The 2021-2026 World Outlook for Anti-Migraine Drugs

£795.00 09 Nov 2026
US Anti-Migraine Drug Market Outlook 2016-2021 Study
99% match

US Anti-Migraine Drug Market Outlook 2016-2021 Study

£595.00 06 Nov 2026
US Anti-Migraine Drug Market Outlook 2023-2028 Study
99% match

US Anti-Migraine Drug Market Outlook 2023-2028 Study

£520.00 07 Nov 2026
Anti-Migraine Drug Outlook in Greater China 2016-2021
99% match

Anti-Migraine Drug Outlook in Greater China 2016-2021

£595.00 25 Aug 2026
Anti-Migraine Drugs in India Outlook 2023-2028 Study
99% match

Anti-Migraine Drugs in India Outlook 2023-2028 Study

£515.00 09 Nov 2026
2025-2030 World Outlook for Anti-Migraine Drugs Study
98% match

2025-2030 World Outlook for Anti-Migraine Drugs Study

Price unavailable
The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs
98% match

The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs

£795.00 07 Nov 2026
US Anti-Migraine Drug Outlook 2023-2028 - Zip Code Study
98% match

US Anti-Migraine Drug Outlook 2023-2028 - Zip Code Study

£490.00 04 Sep 2026
Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)
97% match

Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)

OmniScriptum

£70.00 30 Sep 2026
Migraine and Headache Disorders: Global Perspective - SDG3
97% match

Migraine and Headache Disorders: Global Perspective - SDG3

Springer

£95.74 25 Sep 2026
Management of Migraine Pain: Emerging Opportunities and Challenges
97% match

Management of Migraine Pain: Emerging Opportunities and Challenges

Springer

£162.90 02 Oct 2026
Interventional Management of Migraines and Headache Disorders Book
97% match

Interventional Management of Migraines and Headache Disorders Book

Elsevier

£119.49 02 Oct 2026
Migraine, Words and Fiction
96% match

Migraine, Words and Fiction

Cambridge Scholars Publishing

£67.99 23 Sep 2026
Migraine
96% match

Migraine

IntechOpen

£118.98 12 Sep 2026
The Biochemistry of Migraine
96% match

The Biochemistry of Migraine

Springer

£158.11 19 Sep 2026
Comorbid Conditions in the Treatment of Headache
96% match

Comorbid Conditions in the Treatment of Headache

CRC Press

£75.11 11 Sep 2026
Clinical Scales for Headache Disorders
96% match

Clinical Scales for Headache Disorders

Springer

£95.74 19 Sep 2026
Neuroimaging of Headache Disorders
96% match

Neuroimaging of Headache Disorders

Springer

£101.05 18 Sep 2026
Interventional Management of Headache Pain
96% match

Interventional Management of Headache Pain

Elsevier

£147.99 19 Sep 2026